Retrophin Inc (RTRX)

16.19
NASDAQ : Health Care
Prev Close 16.19
Day Low/High 0.00 / 0.00
52 Wk Low/High 11.60 / 29.64
Avg Volume 482.30K
Exchange NASDAQ
Shares Outstanding 36.73M
Market Cap 601.66M
EPS 3.50
P/E Ratio 6.47
Div & Yield N.A. (N.A)

Latest News

Retrophin (RTRX) Weak On High Volume Today

Retrophin (RTRX) Weak On High Volume Today

Trade-Ideas LLC identified Retrophin (RTRX) as a weak on high relative volume candidate

Retrophin Announces New Data From Physician-Initiated Treatment With RE-024 At The 20th International Congress Of Parkinson's Disease And Movement Disorders

Retrophin Announces New Data From Physician-Initiated Treatment With RE-024 At The 20th International Congress Of Parkinson's Disease And Movement Disorders

RE-024 treatment associated with clinically meaningful improvements in two PKAN patients

First Week of August 19th Options Trading For Retrophin (RTRX)

First Week of August 19th Options Trading For Retrophin (RTRX)

Investors in Retrophin, Inc. saw new options begin trading this week, for the August 19th expiration.

Retrophin (RTRX) Is Today's Strong On High Volume Stock

Retrophin (RTRX) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Retrophin (RTRX) as a strong on high relative volume candidate

Retrophin Acquires Liquid Formulation Of Ursodeoxycholic Acid

Retrophin Acquires Liquid Formulation Of Ursodeoxycholic Acid

U.S. filing for primary biliary cholangitis indication anticipated in 2017

Notable Monday Option Activity: RTRX, TPX, ENOC

Notable Monday Option Activity: RTRX, TPX, ENOC

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Retrophin, Inc. , where a total of 1,726 contracts have traded so far, representing approximately 172,600 underlying shares.

Commit To Purchase Retrophin At $10, Earn 14% Using Options

Commit To Purchase Retrophin At $10, Earn 14% Using Options

Investors considering a purchase of Retrophin, Inc. stock, but cautious about paying the going market price of $17.69/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Today's Weak On High Volume Stock: Retrophin (RTRX)

Today's Weak On High Volume Stock: Retrophin (RTRX)

Trade-Ideas LLC identified Retrophin (RTRX) as a weak on high relative volume candidate

Notable Wednesday Option Activity: RTRX, CONN, RMTI

Notable Wednesday Option Activity: RTRX, CONN, RMTI

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Retrophin, Inc. , where a total of 2,626 contracts have traded so far, representing approximately 262,600 underlying shares.

Retrophin (RTRX) Flagged As Strong On High Volume

Retrophin (RTRX) Flagged As Strong On High Volume

Trade-Ideas LLC identified Retrophin (RTRX) as a strong on high relative volume candidate

Retrophin Completes Enrollment Of Phase 2 DUET Study Of Sparsentan In Focal Segmental Glomerulosclerosis

Retrophin Completes Enrollment Of Phase 2 DUET Study Of Sparsentan In Focal Segmental Glomerulosclerosis

Top-line results expected in the third quarter of 2016

First Week Of RTRX May 20th Options Trading

First Week Of RTRX May 20th Options Trading

Investors in Retrophin, Inc. saw new options become available this week, for the May 20th expiration.

Retrophin Announces New Data Supporting Further Clinical Development Of RE-024 For PKAN At The 2016 American College Of Medical Genetics And Genomics Annual Clinical Genetics Meeting

Retrophin Announces New Data Supporting Further Clinical Development Of RE-024 For PKAN At The 2016 American College Of Medical Genetics And Genomics Annual Clinical Genetics Meeting

Data From Four Posters Include Results of Phase 1 Study, Patient Case Report, and Preclinical Research

Insider Trading Alert - RTRX, SWK And CVGI Traded By Insiders

Insider Trading Alert - RTRX, SWK And CVGI Traded By Insiders

Stocks with insider trader activity include RTRX, SWK and CVGI

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMT, CRHM, CXW, IR, ITG, NWN, PDEX, RDC, RTRX, VCO Downgrades: BK, CEB, CSU, FGBI, GERN, MITT, RLH, SMLP, SMP Initiations: AINC, IZEA Read on to get TheStreet Quant Ratings' detailed report:

Feb. 25 Premarket Briefing: 10 Things You Should Know

Feb. 25 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are edging higher heading into a major day for earnings, as investors await initial jobless claims data and durable goods order numbers.